United States · Platforms & data · The Motley Fool
Which Healthcare ETF Is the Better Buy: VanEck’s Pharma Fund PPH or iShares’ Biotech Fund IBB?
Detailed summary
One fund owns the big drugmakers that pay dividends. The other owns the broader biotech field, where stocks swing more. Here is which fits long-term investors.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)
